Trials / Completed
CompletedNCT01903070
Effects of Linagliptin on Active GLP-1 Concentrations in Subjects With Renal Impairment
EFFECTS OF LINAGLIPTIN ON ACTIVE GLP-1 CONCENTRATIONS IN SUBJECTS WITH RENAL IMPAIRMENT
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 99 (actual)
- Sponsor
- Profil Institut für Stoffwechselforschung GmbH · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This is a bi-centric, prospective, open study comparing the effects of linagliptin on active GLP-1 concentrations in subjects with renal impairment compared to subjects with normal renal function.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Linagliptin |
Timeline
- Start date
- 2013-07-11
- Primary completion
- 2016-04-01
- Completion
- 2016-04-01
- First posted
- 2013-07-19
- Last updated
- 2017-03-03
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01903070. Inclusion in this directory is not an endorsement.